Canopy Growth Corp.: Could it Hit $20 by Year-End?

Canopy Growth Corp. (TSX:WEED) continues to reinforce its leadership position in the medical marijuana market. Is 100% upside on the way?

| More on:

Canopy Growth Corp. (TSX:WEED) is back down to $10 per share and investors are wondering if a double might be in the cards before next year.

Let’s take a look at the current situation to see if this is the right time to add the stock to your portfolio.

Recreational market hopes

Canopy and its peers are trading at sky-high valuations based on investor expectations that Canada will open its recreational marijuana market in July 2018.

It’s easy to see why the hype is holding up.

The federal government has met its targets to date, much to the surprise of many pundits. The task force submitted its report as expected at the end of November, and the Liberals introduced the first look at the legislation April 13, which was right on schedule.

Once passed, the plan will provide a legal framework for the opening of the recreational market by Canada Day next year.

Are investors too optimistic?

The provinces and territories will be responsible for administering the programs in their own back yards. This includes setting prices and overseeing the operations of the industry.

The market appears to believe the provinces will have all their ducks lined up by next summer, but there are serious decisions that have to be made in a short period of time.

Pricing is just one component that will have to be ironed out. If marijuana is taxed too heavily, there is a risk buyers will simply turn to the black market. On the other hand, if the tax revenue is too low, cash-strapped provinces might find themselves facing a new money pit.

Deciding who gets to sell marijuana, and where, is also going to take some careful planning. Given the potential size of the market, there is a lot of money at stake, and politicians are going to want to get it right.

As such, it wouldn’t be a surprise to see the provinces drag their feet on this matter.

Is Canopy attractive?

Canopy is doing all the right things at this point in the market’s evolution.

The company is the dominant player in the growing medical marijuana space, with strong market share in Canada and strategic positions overseas.

Canopy’s leadership was made more evident recently with the announcement that three of Canada’s smaller players have signed up to supply product to Canopy’s Craft Grow program on a wholesale basis.

Through the Tweed Main Street online marketplace, smaller companies and new entrants can expand their reach while avoiding the costs and risks involved in trying to set up their own sales and service platforms.

The market is still evolving, but Canopy is definitely on the right track.

Is 100% upside possible by 2018?

Canopy and its peers appear to be priced for perfection, so any significant move to the upside in the coming months would likely require strong indications from the provinces that they will indeed be ready to launch next summer.

At this point, I have my doubts that will happen, so new buyers of the stock might want to be careful betting on a big gain in the near term. In fact, there is a risk things could go the other way, especially if the provinces start to kick the can down the road.

Canopy is definitely a top name in the sector, but at the current valuation, it might be a good idea to keep any position small.

Looking for more research?

Fool contributor Andrew Walker has no position in any stocks mentioned.

More on Investing

Investing

2 Canadian Stocks to Buy and Hold for the Next 5 Years

These two Canadian stocks are compelling choices to buy and hold for the next five years supported by solid business…

Read more »

ETF stands for Exchange Traded Fund
Dividend Stocks

3 Canadian ETFs I’d Snap Up Right Now for My TFSA

These three high-quality Canadian ETFs are perfect for TFSAs, offering instant diversification to top stocks from around the world.

Read more »

how to save money
Dividend Stocks

The Best Stocks to Buy With $10,000 Right Now

Add these two TSX stocks to your self-directed investment portfolio if you’re seeking long-term buying opportunities in the current climate.

Read more »

coins jump into piggy bank
Dividend Stocks

How to Convert $25,000 in TFSA Savings Into Reliable Cash Flow

With $25,000 invested into Fortis (TSX:FTS) stock, you can get some cash flow in your TFSA.

Read more »

rising arrow with flames
Investing

2 Superb Canadian Stocks Set to Surge Into 2026

The durable demand for their products and services, and solid execution make them superb stocks to buy and hold.

Read more »

dividends can compound over time
Dividend Stocks

2 Dividend Stocks to Lock In Now for Decades of Passive Income

These two Canadian dividend stocks are both defensive and generate tons of cash flow, making them ideal for passive-income seekers.

Read more »

man looks surprised at investment growth
Dividend Stocks

If I Could Only Buy and Hold a Single Stock, This Would Be it

Brookfield (TSX:BN) is a very high-quality stock.

Read more »

ETF is short for exchange traded fund, a popular investment choice for Canadians
Dividend Stocks

The ETFs That Canadians Are Sleeping On (But Shouldn’t Be) Right Now

These three high-quality Canadian ETFs are perfect for investors in 2026, especially with increasing uncertainty and volatility in markets.

Read more »